February 14, 2008
Embassy Suites RTP East
Cary, NC
Speaker Bios
John D. Allison
Partner
Kennedy Covington
John Allison is a partner in the business law department of Kennedy Covington. He has represented clients in a variety of complex transactions, including mergers, acquisitions, and divestitures. As the operations of John's clients have spread overseas, he has also been involved in international joint ventures and other foreign projects.
John has experience handling international matters in over 30 foreign countries that involved issues relating to the Foreign Corrupt Practices Act, U.S. export control laws, antiboycott laws, bank guarantees, international treaties and conventions, incoterms, dealer protection laws, currency exchange controls, and other matters impacting cross-border transactions. He is also exclusive counsel for a Fortune 100 company for Hart-Scott analysis and pre-merger notification filings with the Federal Trade Commission and the Department of Justice.
John served as law clerk to the Honorable Robert F. Chapman, Fourth Circuit Court of Appeals, 1991-92.
Janet Babin
National Reporter
North Carolina National Public Radio
Janet Babin is a national reporter with Marketplace, the business show heard on National Public Radio stations across the country. Marketplace reaches 9 million listeners and podcasters each week.Since 2005, Janet has been the Marketplace Innovations Desk reporter at North Carolina Public Radio, WUNC.
From her base in the Triangle, Janet has covered many innovations stories. Her focus is on patents, technology, biotechnology, telecommunications and inventors. Before her work with Marketplace, Janet hosted a call in show at Cleveland public radio station WCPN. She was also a political reporter. She’s worked for National Public Radio’s Day to Day Show. She’s filled in on the national desk at NPR’s Washington DC headquarters. Her stories have aired on many programs, including Morning Edition, All Things Considered and On The Media. Janet’s stories have also aired on Voice of America and CNN Radio. Janet has won several awards throughout her career. In 2001, she was a finalist for a Gerald Loeb Award for Business Reporting.
Neil Bagchi
Corporate Associate
Kennedy Covington
Neil Bagchi is a corporate associate with the Business & Technology and International Practice Groups at Kennedy Covington, one of the largest business transactional law firms in North Carolina. He is also one of the key members of the firm’s India Advisory, the first India-focused law firm based practice in the Southeast. The India Advisory provides business and legal advice to US companies interested in doing business in India and Indian companies interested in doing business in the US. Neil’s practice focuses on assisting clients develop business relationships with Indian partners, structuring such relationships in a tax efficient and legally compliant manner, and drafting the documents governing such relationship.
Neil is the author of the chapter entitled “Investment in India from a U.S. Perspective,” in the second edition of Corporate Counsel's Guide to Doing Business in India, winner of the IndUS Business Journal's 2007 Award of Excellence in the Legal Services category.
Neil received both his undergraduate and law degrees from the University of North Carolina at Chapel Hill, where he was a Morehead Scholar.
Kim Beer
Product Development Manager, Global Health Technology Group
RTI International
Mr. Beer is the Product Development Manager for the Global Health Technology group at RTI International. Through the new program (Venture Investment Technical Assistance -VITA), he is leading an effort providing business development and commercialization assistance to early-stage medical device companies seeking to enter markets in developing countries and emerging markets.
From 1997 to 2002, Mr. Beer served as Director of Marketing, Technology & Logistics for Ipas, a Chapel Hill-based international not-for-profit woman’s health organization involved in training, manufacturing, marketing, research and policy worldwide. In this capacity, Mr. Beer built an international marketing organization with staff in 10 developing countries. Before joining RTI, Mr. Beer consulted with the World Bank and United Nations Population Fund, mostly on distribution and logistics issues pertaining to essential medicines, contraceptives and access to HIV/AIDS medicines. He has also served as the Business Development Manager for Surgicot, a specialized medical device manufacturer located in RTP. Mr. Beer led the company's mergers & acquisitions program, and managed a line of medical packaging products.
From 1989-1991 he was stationed in Zambia for the Danish Association for International Development, building a wholesale business supplying consumer goods to village shops across the Southern Province of the country.
He holds an MBA from the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill, with a focus on environmental issues. Mr. Beer is member of the Board of Directors and past Chair of the NC Sustainable Energy Association. He is a native of Denmark.
Oren J. Cohen, M.D.
Chief Medical and Scientific Officer
Quintiles Transnational Corp
Oren J. Cohen, M.D. is Chief Medical and Scientific Officer for Quintiles Transnational Corp, a global contract research organization with over 19,000 employees in 54 countries. Dr. Cohen is also Consulting Professor of Medicine on the Infectious Diseases faculty at Duke University Medical Center. A magna cum laude graduate of Brandeis University, Dr. Cohen is also an Alpha Omega Alpha honors graduate of the Duke University School of Medicine. Dr. Cohen completed an internship and residency in Internal Medicine at the New York Hospital/Cornell University Medical Center, where he served as Assistant Chief Resident in 1989-1990; he received the Richard Bowman award for dedication to medicine in 1990. He served from 1990-1991 as Clinical Instructor in Medicine at the New York Hospital’s AIDS treatment center. Dr. Cohen completed his fellowship in Infectious Diseases in 1994 at the National Institute of Allergy and Infectious Diseases (NIAID), and spent seven years conducting basic and clinical HIV/AIDS research as a Fellow, Clinical Associate, and Medical Officer in the NIAID Laboratory of Immunoregulation. Dr. Cohen was appointed Assistant Director for Medical Affairs at NIAID, where he also served on the Department of Health and Human Services/Henry J. Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV Infection, which formulates the national Guidelines for the Use of Antiretroviral Agents. Dr. Cohen joined Quintiles as a medical advisor in 2001, and was appointed Chief Medical and Scientific Officer in 2004. Dr. Cohen’s industry experience is concentrated in antiviral drug development, with particular emphasis in the areas of HIV, hepatitis B and hepatitis C global clinical trials.
Dr. Cohen is board-certified in Infectious Diseases and Internal Medicine, and is a Fellow of the Infectious Diseases Society of America. Dr. Cohen is the author of more than 50 scientific papers and book chapters, and holds a U.S. patent for HIV-related peptides derived from HIV-infected long-term non-progressors.
Guy Harvey
Senior Vice President & Managing Principal, Corporate Services
The Staubach Company - Carolinas, Florida & Tennessee
Guy is the Managing Principal for the Raleigh office of Staubach Corporate Services. In this role, Guy sets the tone for how the Raleigh office serves its clients. He instills basic values in his staff while staying focused on his primary responsibility - delivering tangible results to clients. With more than 18 years experience in managing complex real estate projects for hundreds of clients, Guy has consistently achieved economic and time savings for his clients, resulting in a 10 – 20% reduction in total occupancy costs. His experience spans 20 states and includes assisting with corporate real estate outsourcing and portfolio management, leasing, renegotiations, sales, purchases, build-to-suit projects and real estate asset consulting throughout North America.
He was recently recognized by Business Leader magazine as one of its Movers & Shakers, a select group of professionals who are making an impact in their industries as well as the Research Triangle Community. Over his career, Guy has been consistently ranked as one of Triangle Business Journal’s Commercial Real Estate Heavy Hitters. He was also named a Top Achiever for the Staubach Company in 2007.
Guy received his Bachelor of Business Administration from East Carolina University. He serves on the board of directors for the Triangle Down Syndrome Network and CED.
Chris James
Vice President of Corporate Marketing
Cree, Inc.
As Vice President - Marketing, Chris is responsible for the development of corporate brand and business strategies, as well as for execution of those strategies through proactive outbound marketing, business development, and customer service activities at the corporate level. He joined Cree in December 2004 as Marketing and Sales Manager for Cree Lighting.
Prior to joining Cree, Chris served as vice president of Research Memberships and Publishing at the benchmarking firm Best Practices. Chris has also been vice president of marketing and business development for three high-tech start-ups, led Ernst & Young's High-Growth Consulting Supply Chain Practice, and held a number of management positions with the Components Group at Hewlett-Packard Company.
Chris holds undergraduate degrees in electrical engineering and German studies, and a master's degree in business administration from Stanford University.
Art Pappas
Managing Partner
Pappas Ventures
Art has over 30 years of operating experience as a pharmaceutical and biotechnology industry executive and venture capital investor in life science companies. He is the founder of Pappas Ventures and has assembled a team of investment, biotechnology and medical experts who oversee the funds’ investments. Prior to founding Pappas Ventures in 1994, Art held senior level leadership positions at several multinational pharmaceutical companies. He was an executive member of the board of directors of Glaxo Holdings plc, for which he was responsible for international operations including research, development and manufacturing. Art previously was Vice President of Commercial Operations for Abbott International Ltd., and he held various executive operating positions with Merrell Dow Pharmaceuticals and the Dow Chemical Company, in the United States and internationally. Among the companies for which he currently serves as a director are: AtheroGenics (Nasdaq: AGIX), which conducted a successful IPO in 2000, BrainCells, Genstruct and LEAD Therapeutics. He was the founding CEO and is currently the chairman of CoLucid Pharmaceuticals. He previously served on the boards of Embrex (Nasdaq: EMBX), Quintiles Transnational (Nasdaq: QTRN) and Valentis (Nasdaq: VLTS). He was on the board of directors of Syntonix Pharmaceuticals prior to its acquisition by Biogen Idec in early 2007.
Art is a member of the National Venture Capital Association (NVCA) Medical Industry Group Advisory Board and a member of the board of directors of the North Carolina Biotechnology Center. Art is a decorated Vietnam veteran, having served as an officer in the US Army 101st Airborne Division and the Special Forces.
Marshall Phelps
Corporate Vice President and Deputy General Counsel, Intellectual
Property
Microsoft Corp.
As Microsoft Corp.'s corporate vice president and deputy general counsel for intellectual property, Marshall Phelps supervises Microsoft's intellectual property groups, including those responsible for trademarks, trade secrets, patents, licensing, standards and copyrights. He oversees the company's management of its intellectual property portfolio, which comprises some 3,000 U.S.-issued patents, their foreign counterparts and more than 11,000 trademark registrations worldwide. In addition, Phelps helps lead Microsoft's ongoing work with other companies in the technology industry to broaden awareness of intellectual property issues.
Phelps joined Microsoft in June 2003 after a 28-year career at IBM Corp., where he served as vice president for intellectual property and licensing. Phelps was instrumental in IBM's standards, telecommunications policy, industry relations, patent licensing program and intellectual property portfolio development. Also, Phelps helped establish IBM's Asia Pacific headquarters in Tokyo and served as the company's director of government relations in Washington, D.C. Upon retiring from IBM in 2000, he spent two years as chairman and chief executive officer of Spencer Trask Intellectual Capital Company LLC, which specialized in spinoffs from major corporations such as Motorola Inc., Lockheed Martin Corp. and IBM. Phelps holds a bachelor of arts degree from Muskingum College, a master of science degree from Stanford Graduate School of Business and a doctorate from Cornell Law School.
Terrance Philips
Vice President
SVB Global
Christopher Price, Ph.D.
President & CEO
LaamScience
Dr. Price is a serial entrepreneur, inventor, consultant, and educator in life sciences with more than 20 years of senior executive R&D, business development, and management experience in biotechnology, pharmaceuticals, medical devices, and specialty chemicals. He is currently the President and CEO of LaamScience in Raleigh, NC, a spinout of North Carolina State University focused on nanoscale coatings that provide anti-viral and anti-bacterial activity for textile-based products.
His biotechnology companies have brought 4 therapeutic products into clinical study (one is marketed and the others remain in ongoing clinical studies) and 2 consumer products into the market. He has raised more than $100 million of equity and debt and completed a number of licensing deals potentially worth more than $400 million plus royalties.
Price received his Ph.D. in biology from Syracuse University and an MBA from the Sloan School (MIT). He is an author on 28 peer-reviewed scientific papers, a book on global patent strategy (Wiley, 2007), and inventor on 34 U.S. patents and patent applications. He is a Director of Otothera, Inc., a tinnitus therapy company, an advisor to OccuSciences, a retinal imaging company, and a member of the scientific and clinical advisory boards of The Endpoint Group and of ConjuGate, Inc., an injectable drug delivery firm.
Arti K. Rai
Professor of Law
Duke University
Arti Rai is an expert in patent law and law and the biopharmaceutical industry. Her current research examines patterns of software and pharmaceutical patent filing in India post-TRIPs. Under the auspices of an NIH grant, she is also studying intellectual property issues raised by collaborative R&D in areas ranging from synthetic biology to drug development.
Her recent publications include “Who's Afraid of the APA? What the Patent System Can Learn from Administrative Law” 95 Georgetown Law Journal269 (2007) (with Stuart Benjamin); “Open and Collaborative Research: A New Model for Biomedicine,” in Intellectual Property Rights in Frontier Industries: Biotech and Software (AEI-Brookings Press, 2005); and “Finding Cures for Tropical Diseases: Is Open Source an Answer?” Public Library of Science: Medicine (2004) (with Stephen M. Maurer and Andrej Sali).
Professor Rai joined the Duke Law faculty in 2003. In the winter of 2007, Rai was the Hieken Visiting Professor in Patent Law at Harvard Law School. In the fall of 2004, Rai was a Visiting Professor at Yale Law School. Prior to joining Duke, she was on the faculty of the University of Pennsylvania Law School, where she was also a visiting professor in Fall 2000.
Rai graduated from Harvard College, magna cum laude, with a B.A. in biochemistry and history (history and science), attended Harvard Medical School for the 1987-1988 academic year, and received her J.D., cum laude, from Harvard Law School in 1991.
Mark Rostick
Managing Director
Intel Capital
Mark Rostick directs Intel Capital’s investment activities on the east coast, including eastern Canada, Boston, NY, DC & the Southeast. Mark’s team makes and manages investments across all areas of investment focus for Intel and has particular interest in opportunities in the semiconductor, enterprise, wireless and digital media sectors. He has worked with Intel Capital since 1998, both in Silicon Valley and on the east coast, in a variety of roles. Before joining Intel Capital, he worked in Intel’s strategic software licensing group.
Prior to joining Intel, Mark worked for Turner Broadcasting marketing its cable networks in South America. Previously, he spent five years as a practicing attorney specializing in tort and business litigation. He began his career with Bank of America. Mark earned a JD and an International MBA from the Moore School at the University of South Carolina
Alex Schröder
Vice President of Corporate Development
Noël Group, LLC
Mr. Alex Schröder is Vice President of Corporate Development at Noël Group, LLC, an industrial holding company that manages a portfolio of manufacturing businesses with eleven sites around the world. In his role, he oversees strategic planning, business development, and acquisition activities for Noël Group and its portfolio companies.
Prior to his position, Mr. Schröder served in various management roles within Noël Group’s operating companies. He also spent three years as Director of Sales & Marketing at Trexel, Inc., a Boston-based MIT spin-off. As a multi-cultural leader with a broad business background, including experience in several start-ups and turnarounds as well as joint ventures and acquisitions, he has been a driving force behind the company’s expansion into new technologies and markets, including the more recent launch of the company’s activities in China.
Mr. Alex Schröder earned an MBA from the Harvard Business School and a Bachelor of Applied Economics from the Université Catholique de Louvain in Belgium. He speaks four languages fluently and resides in Raleigh with his wife and two children.
Bob Sutor, Ph.D.
Vice President of Open Source and Standards
IBM Corporation
Dr. Bob Sutor is the Vice President of Open Source and Standards for the IBM Corporation. In this role he has the responsibility for driving and executing the cross-company business and technical strategy for open standards and open source as they relate to software, hardware, services, vertical industries, and emerging markets. Previously, Sutor was Director of WebSphere Product and Market Management. This included ownership of the WebSphere Application Server, WebSphere MQ, and the WebSphere Business Integration product lines, as well as web services and Service Oriented Architecture.
A 24 year veteran of IBM, Sutor worked for 15 years in IBM Research, specializing in symbolic mathematical computation and Internet publishing. He co-authored the books Axiom: The Scientific Computation System and The LaTeX Web Companion. Sutor was a co-author of the W3C Recommendation Mathematical Markup Language (MathML) as well as the W3C Recommendation Document Object Model Level 1.
In 1999 Dr. Sutor moved to the IBM Software Group and focused on jump starting industry use of XML. This led to positions on the Board of Directors of the OASIS standards group and the vice chairmanship of the ebXML effort, a joint OASIS/United Nations endeavor. Sutor then led IBM’s industry standards and Web services strategy efforts.
Dr. Sutor is a widely read blogger and is a frequent speaker around the world on open standards, open source, web services, and Service Oriented Architecture. He is widely cited in the press and was featured in interviews in the Harvard Business Review, CNET, eWeek, and InfoWorld. In 2006 Sutor was named as one of Computer Business Review’s “Open Source VIPs.”
Dr. Sutor has an undergraduate degree from Harvard College and a Ph.D. from Princeton University, both in Mathematics.
Ted Zoller
Executive Director,
Center for Entrepreneurial Studies and Adjunct Assistant
Professor of Entrepreneurship
UNC Kenan Flagler Business School
Ted Zoller is an assistant professor of entrepreneurship and executive director of the Center for Entrepreneurial Studies. He oversees the Center's teaching and outreach programs, and is the primary liaison to UNC’s Carolina Entrepreneurial Initiative and to partners in the Research Triangle entrepreneurial community. Professor Zoller has taught entrepreneurship courses at UNC Kenan-Flagler since 1999. He is the founding instructor of "Launching the Venture," which has increased the number of companies to spin-off from UNC-Chapel Hill. He is a former associate dean, high-tech entrepreneur and American Management Systems, Inc. principal. He was founding director of economic development at the College of William & Mary, where he developed Jefferson Park, an advanced technology research park.
He teaches new ventures, business plan and enterprise development courses. He has taught and consulted with entrepreneurial firms and serves on the boards of the Council of Entrepreneurial Development, Southeast TechInventures, NCIdea and CollectiveIQ Private Equity. Professor Zoller also teaches and consults extensively overseas, teaching in UNC Kenan-Flagler’s GLOBE program and the European Summer School of Advanced Management in Denmark, developing an entrepreneurial academy with INITs, the leading tech-transfer organization in Vienna, and teaching in the Global Scholars program, a joint initiative of the British National Council of Graduate Entrepreneurship and the Kauffman Foundation. He is completing his PhD at UNC-Chapel Hill. He has a bachelor’s degree from William & Mary and master’s degrees from Syracuse University and the University of Virginia.